Gary Herman

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19”.

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

New England Journal of Medicine(2021)10.1056/nejmoa2109682

N/A

9.8DataRank · unranked

480 citations

Eduardo Forleo‐Neto, Bret J. Musser, Flonza Isa, Kuo‐Chen Chan, Neena Sarkar +31 more

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

Nature Communications(2023)10.1038/s41467-023-39292-w

N/A

1.9DataRank · unranked

44 citations

Meagan P. O’Brien, Jonathan Fintzi, Michael P. Fay, David C. Montefiori, Allyson Mateja +19 more

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial

Clinical Infectious Diseases(2022)10.1093/cid/ciac153

N/A

1.3DataRank · unranked

41 citations

David J. Lederer, Rafia Bhore, Negin Hajizadeh, Gerard J. Criner, Romana Hosain +35 more

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00416-9

N/A

0.561DataRank · unranked

41 citations

Meagan P. O’Brien, Eduardo Forleo‐Neto, Neena Sarkar, Flonza Isa, Peijie Hou +88 more

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies

Cell(2021)10.1016/j.cell.2021.06.002

N/A

0DataRank · unranked

240 citations

Alina Baum, Elzbieta Wloga, Kristen E. Pascal, Stephanie Giordano, Benjamin O. Fulton +32 more

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad598

N/A

0DataRank · unranked

4 citations

Meagan P. O’Brien, Andrea T. Hooper, Eduardo Forleo‐Neto, Flonza Isa, Peijie Hou +8 more

A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad271

N/A

0DataRank · unranked

1 citations

Meagan P. O’Brien, Brian Snow, Flonza Isa, Eduardo Forleo‐Neto, Kuo‐Chen Chan +5 more

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

UNC Libraries(2025)10.17615/f196-ys27

N/A

0DataRank · unranked

0 citations

Ned Braunstein, K. C. Turner, Neena Sarkar, Myron S. Cohen, Adnan Mahmood +25 more

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection

UNC Libraries(2025)10.17615/8hrb-tr84

N/A

0DataRank · unranked

0 citations

Gary Herman, Boaz Hirshberg, Bret J. Musser, Andrea T. Hooper, Flonza Isa +8 more

Casirivimab and Imdevimab Treatment in Seropositive, Hospitalized COVID-19 Patients With Non-neutralizing or Borderline Neutralizing Antibodies

medRxiv(2022)10.1101/2022.06.14.22276389

N/A

0DataRank · unranked

0 citations

Selin Somersan-Karakaya, Shane McCarthy, Eleftherios Mylonakis, Shazia Ali, Jingning Mei +9 more